We are working with scientists and clinicians worldwide and won’t stop until we find treatments and cures for all muscle-wasting conditions.

Since 1959, the generosity and dedication of our supporters have meant we’ve been able to invest more than £55 million in high quality research.

We use a robust international peer-review system, and have laid the foundations for the first potential treatments for some muscle-wasting conditions.

We are pressing to ensure early participation for UK patients in clinical trials. We fund clinical trial co-ordinators and the national neuromuscular database to ensure vital patient information is available to clinicians and researchers.


  • Chemistry Research Laboratory, Oxford

    Update on utrophin up-regulation programme

    Muscular Dystrophy UK visited Oxford to get an update on progress

    Read more »

  • phase 3 clinical trial on idebenone for Duchenne muscular dystrophy

    Idebenone clinical trial results for Duchenne

    Professor Buyse shortly to present results

    Read more »

  • Ethnicity and loss of walking ability in Duchenne muscular dystrophy

    Ethnicity and loss of walking ability in Duchenne muscular dystrophy

    Difference in genes may influence the severity of Duchenne

    Read more »

  • myotonic dystrophy type 1

    Update on research into myotonic dystrophy type 1

    Find out about research into myotonic dystrophy type 1.

    Read more »

Events calendar

  • 8

    Yorkshire Transition information event – Bradford

    8 April 2015

    Read more »

  • 10

    Glasgow Central Station Collection

    10 April 2015

    Read more »

  • 13

    East of England Muscle Group in Colchester

    13 April 2015

    Read more »

Near you

Find support and services in your area:

Keep in touch
- Enter Your Location -
- or -